You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 41 No. 7, July 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  REGULAR DEPARTMENTS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Errors in Administration of the Dexamethasone Suppression Test

Mantosh J. Dewan, MD; D. P. Devanand, MD; Anand K. Pandurangi, MD
Department of Psychiatry Upstate Medical Center 750 E Adams St Syracuse, NY 13210; Department of Psychiatry Yale University School of Medicine 34 Park St New Haven, CT 06519; Department of Psychiatry Columbia University College of Physicians and Surgeons 722 W 168th St New York, NY 10032

Arch Gen Psychiatry. 1984;41(7):725.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Greden et al1 reported that some of their patients with suppressive responses to the dexamethasone suppression test (DST) became nonsuppressors after withdrawal from antidepressants, and they hypothesized a causal effect. We have recently reported2 the case of a non-depressed patient with a suppressive DST response in whom withdrawal from antipsychotics led to nonsuppression in response to the DST (a positive DST) on two separate occasions. The antipsychotic used was piperacetazine, which has marked anticholinergic properties.

Both reports have suggested that anticholinergic withdrawal with subsequent cholinergic overdrive induces nonsuppression in response to the DST, as happens with the administration of physostigmine to normal subjects.3 Taken together, these data provide strong support for this being the mechanism of action. Carroll et al4 reported that neuroleptic treatment has no effect on the DST, but it is possible that withdrawal of neuroleptics with strong anticholinergic properties may give . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.